Chandrika , G. and Natesh K, K. and Ranade ., D. and Chugh , A. and Shastry P1., P. (2016) Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling. Sci. Report, 6. p. 22455.

Preview

Text 10.Dr. Shastry P. (Sci. Report) open access.pdf Download (852Kb) | Preview

Abstract

Glioblastoma (GBM) is the most aggressive type of brain tumors in adults with survival period <1.5 years of patients. The role of mTOR pathway is documented in invasion and migration, the features associated with aggressive phenotype in human GBM. However, most of the preclinical and clinical studies with mTOR inhibitors are focused on antiproliferative and cytotoxic activity in GBM. In this study, we demonstrate that mTOR inhibitors-rapamycin (RAP), temisirolimus (TEM), torin-1 (TOR) and PP242 suppress invasion and migration induced by Tumor Necrosis Factor-α (TNFα) and tumor promoter, Phorbol 12-myristate 13-acetate (PMA) and also reduce the expression of the TNFα and IL1β suggesting their potential to regulate factors in microenvironment that support tumor progression. The mTOR inhibitors significantly decreased MMP-2 and MMP-9 mRNA, protein and activity that was enhanced by TNFα and PMA. The effect was mediated through reduction of Protein kinase C alpha (PKC-α) activity and downregulation of NFκB. TNFα- induced transcripts of NFκB targets -VEGF, pentraxin-3, cathepsin-B and paxillin, crucial in invasion were restored to basal level by these inhibitors. With limited therapeutic interventions currently available for GBM, our findings are significant and suggest that mTOR inhibitors may be explored as anti-invasive drugs for GBM treatment.

Item Type:	Article
Additional Information:	This is Open access article for full text click above weblink
Subjects:	Cancer Biology
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	01 Apr 2016 09:33
Last Modified:	22 Feb 2021 11:43
URI:	http://nccs.sciencecentral.in/id/eprint/234

Actions (login required)

View Item